AMT is a specialist chemical company focused on the development and commercialisation of new Intellectual Property and products, including organosilicon and bioactive nucleoside analogues.
Advanced Molecular Technologies Pty Ltd was founded by Dr. Sebastian Marcuccio in May 2005.
AMT is a specialist biotech company focused on the development and commercialisation of new products.Â
The work within the company is currently focused on the development of bioactive products for pharmaceutical
and veterinary applications, as well as, a range of new building blocks for use in the pharmaceutical and fine chemical industries.Â In addition AMT undertakes contract services in its areas of expertise or interest.
Through its senior scientists Advanced Molecular Technologies has specialist expertise in:
Cross coupling chemistries (Hiyama, Suzuki etc)
Organoboron products and reagents
Organosilicon products and reagents
Nucleoside and nucleotide products.